FDA Cracks Down on Custom-Made Hormones
January 9, 2008 By RANDOLPH E. SCHMID, AP Science Writer(AP) -- Government health officials began cracking down Wednesday on Internet sales of custom-mixed hormones for menopausal women, a market created when doctors deemed prescription estrogen therapy too risky for many patients.
Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .
Similar stories from PHYSorg:
Long-term hormone replacement therapy increases breast cancer risk
May 28, 2008 |
4.3 / 5 (3) |
0
Study finds it pays to be heart smart if considering hormone therapy
May 22, 2008 |
5 / 5 (1) |
0
New evidence of hormone therapy causing breast cancer, professor says
Feb 04, 2009 |
5 / 5 (1) |
1
Breast cancer rates fall steeply in women who quit combination hormones, follow-up shows
Feb 05, 2009 |
not rated yet |
1
'Bioidenticals' not FDA-approved, contain estrogen
Oct 25, 2009 |
1 / 5 (1) |
1
Dec 22, 2009
